and regain confidence
in your catheter care
The power to make a change is now in your hands with UroShield's ready to use solution.
UroShield's innovative technology uses low frequency ultrasound to help prevent bacteria from building up on urinary catheters.
The small external device can be used with any indwelling catheter to help prevent infection, pain, blockage and spasm, often caused with long term use.
with 48% less
Studies show that UroShield drastically reduces bacteria in adults using it correctly.
Following an 8 week study detecting bacteria levels in patients, a 48% lower rate was found in those who used UroShield compared to those who didn't.
Spend more days
the way you want
No side effects or additional antibiotics
UroShield is made to be easily integrated into your routine, working in tandem with your existing catheter treatment without the need for additional antibiotics or extensive support.
With no side effects either, you'll never need to worry about taking extra precautions; giving you more time to enjoy the days and experiences you value most.
Less painful time in hospital
They say it's the little things that count, and we appreciate that for the 273,000 patients estimated to develop a Catheter-Associated UTI, every moment without worry does too.
That's we're proud that UroShield targets preventable infections and reduces the need for lengthy, uncomfortable treatment time away from family and friends.
Is UroShield right for me?
We're here to help.
If you answered "yes" to all three questions, UroShield can help offer you immediate relief. Let our helpful customer service team support you with introducing UroShield to your care.
Frequency of Use
Do you use a long-term indwelling catheter?
Frequency of Use
Do you suffer from recurring infections, pain, spasm and / or blockages?
Will you be due for a catheter change within the next 12 weeks?
"It's had a huge impact on my day to day life, giving me more confidence in my catheter, allowing me to enjoy days out and even go on holiday."
Patient Feedback, UroShield Study